S.Amdt. 4519

SA 4519. Mr. LUJAN submitted an amendment intended to be proposed by
him to the bill S. 1383, to establish the Veterans Advisory Committee
on Equal Access, and for other purposes; which was ordered to lie on
the table; as follows:

At the appropriate place, insert the following:

SEC. __. GAO STUDY ON DOGE MEDICAL RESEARCH FUNDING
REDUCTIONS.

(a) In General.--The Comptroller General of the United
States (referred to in this section as the ``Comptroller
General'') shall conduct a study on the impact of reductions
in Federal funding recommended by the Department of
Government Efficiency on the following types of medical
research:
(1) Neurological research, including relating to stroke,
Alzheimer's disease and related dementia, and other
neurological conditions.
(2) Cancer research, including basic, translational, and
clinical cancer research.
(3) Pandemic preparedness, including research and
development related to emerging infectious diseases, vaccine
development, surveillance, and public health preparedness.
(4) HIV/AIDS research, including relating to prevention,
treatment, and cure of HIV/AIDS.
(5) Women's health research, including relating to
addressing conditions and health outcomes affecting women
across the lifespan, including maternal health.
(b) Requirements.--The study under subsection (a) shall
include--
(1) an analysis of changes in funding levels over the 4-
year period immediately preceding the date of enactment of
this Act for each type of research described in paragraphs
(1) through (5) of subsection (a);
(2) an assessment of the impact of such funding changes
on--
(A) the number and scope of active research projects;
(B) clinical trials and translational research;
(C) workforce capacity, including researchers, clinicians,
and trainees;
(D) the pace of scientific discovery and innovation;
(E) research institutions in each State;
(F) neurological and cancer research relevant to veterans
and service members; and
(G) the global leadership of the United States in
biomedical research;
(3) an evaluation of any impacts on patient outcomes, where
data is available;
(4) an analysis of geographic disparities, including
impacts on rural and underserved communities;
(5) any delays in life-saving treatments attributable to
such changes in funding levels; and
(6) such recommendations as the Comptroller General
determines appropriate.
(c) Report.--Not later than 18 months after the date of
enactment of this Act, the Comptroller General shall submit
to Congress a report on the study conducted under subsection
(a).
______